Member Info for Baffyman

Https://t.co/iLkyecj8Jo

At v early stage

JT, brilliant post.

To AS & TG 2.5m in total @10p

Agree all's well med term.

For the charties, expect a dip to around 112p then next leg up is a big un to over 150p.

Great post Chrisbak, especially like this paragraph which is spot on:

"Meanwhile shorters with deep pockets and their paid rumour mongers and lackeys who populate the Punch and Judy section of the LSE board continue to try to persuade fearful, fragile minded investors to sell their shares."

All capital letters has disappeared.... apologies

i'm not trying to be smart. as dtw states you are always that what you say is a fact, when they are your opinions.

some may be good opinions, but not always.

give the ceo a break, he's done an overall sterling job with the company so far.

good analogy is my golf club, where we have 400 greenkeepers, but only one that is qualified and in charge of decision making, it's laughable.

can't believe how so many are invested here but thinks the main man is poor. surely anyone with a brain that thinks this should sell up and move on.

as for your aggressive response, you don't own the board "you complete smart ****"

"the market doesn’t trust Avacta based on previous actions, that’s just facts. "

Show me these facts plse.

As Dr Tap is taking the lead role in USA, things may hot up very quickly.

To get FDA breakthrough a treatment must show one of a few things , including:

"A significantly improved safety profile compared to available therapy (e.g., less dose-limiting toxicity for an oncology agent), with evidence of similar efficacy"

AS recently quoting improved efficacy recently as well

AND

A drug that receives Breakthrough Therapy designation is eligible for the following:

"All Fast Track designation features

Intensive guidance on an efficient drug development program, beginning as early as Phase 1

Organizational commitment involving senior managers"

Surely we qualify.......

Https://twitter.com/i/status/1701892668144443600

hope this helps

Yes I think TW was instructed by the spivs to drop negative news yesterday, they buy in late and get an extra 7%, knowing that an RNS was out this morning.

20% profit on my trading pot is not bad in 2 weeks though.

Each to their own and I would not trade my main holding, just trying to increase no. of shares for med/long term.

Gje, "Sorry to say but this is Albert from the telegram boiler room group. He and ophidian have been pushing their TA bs on there for months now, and most of it has transpired to be utter tosh."

Well I made 20% in my trading pot following the guidelines.

If that's utter tosh, can I have more tosh.

PS there was an undefined volume trade at 1010hrs also.

Definitely an orchestrated drop when this article came out at 11am, from 112 to 108 imo.

Who says that AIM and the connected spivs in the city are not bent?

And LSE in this?. make your own mind up, just asking questions

Read quickly as it could be erased lol

Down at 112 now, which should be the bottom of wave 4, wave 5 to start and up she will go.

(Good support level also).

Roll on next few weeks if news feed is as good as expected.

Exciting times

Or just natural fallback whilst there is no news.

Strangy,

the thing that most people don't grasp is that news and TA run alongside and blend with each other.

So yes, TA on its own its not half as effective, so people seem to sit in one camp or the other.

I agree, without doubt TA outcome changes totally on news.

On personal issues you bring up, I'll leave that in your hands

Wow Wyn, I agree totally with one of your posts.

On other channels, twice recently TA views have been expressed and they've worked out perfectly.

Just alone on these two moves, a total of 25% profit could have been made, and this move has not quite finished yet.

Fact, not opinion, like 90% of posts on here.

I'm an investor ,so haven't traded this way, but generally it does work (not all time)

glalth

Interesting:

"Flew up to (and back from!) Newcastle yesterday to meet with @BSF_Enterprise and tour the labs and offices.

Incredibly impressed with #BSFA's operations. Got to see an almost completed square of lab-grown animal skin (10 cm²) that will find its way to a luxury leather goods manufacturer, for its tanners to test. Surreal stuff.

Current lab has a production capacity of 2,500 litres of City-Mix per annum (at £400/l, that's £1m in revenue pa). However, the plan is to out-license the product to the largest cell culture media manufacturers and consumers out there (the likes of Danaher, Thermo Fisher, and the largest of the cultivated meat manufacturers) - who could then produce all the City-Mix that they require for their media, in-house.

The market for cell culture media (just for use in the biotech/pharmaceutical industries) is already circa $5bn per annum. Over the next 10-20 years, its use in the cultivated meat industry is exacted to grow to 10-20x of the amount used in biotech/pharma.

There's loads going on with BSFA's structured products too. I was able to see (and hold) a lab-grown cornea yesterday - which could be used both for medical uses and industrial applications. I believe we will also shortly hear of BSFA's plans to progress its Tissue Templating platform in creating cultivated meats, beyond the pork fillet it already has successfully developed.

Multiple partnerships with massive companies across numerous industries are in the offing. I continue to add as and when I can on those bizarre sell-offs (now at 2.6%), in anticipation of a major rerating of the shares in the not too distant future."